These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
509 related items for PubMed ID: 15193689
21. Electrocardiographic Q-wave "remodeling" in reperfused ST-segment elevation myocardial infarction: validation study with CMR. Florian A, Slavich M, Masci PG, Janssens S, Bogaert J. JACC Cardiovasc Imaging; 2012 Oct; 5(10):1003-13. PubMed ID: 23058067 [Abstract] [Full Text] [Related]
22. Prediction of life-threatening arrhythmic events in patients with chronic myocardial infarction by contrast-enhanced CMR. Boyé P, Abdel-Aty H, Zacharzowsky U, Bohl S, Schwenke C, van der Geest RJ, Dietz R, Schirdewan A, Schulz-Menger J. JACC Cardiovasc Imaging; 2011 Aug; 4(8):871-9. PubMed ID: 21835379 [Abstract] [Full Text] [Related]
23. Sector-Based Assessment of Infarct Size on Late-Gadolinium-Enhancement MRI in a Mouse Model of Acute Myocardial Infarction. Park C, Park EH, Chang K, Hong KS. Int Heart J; 2016 Dec 02; 57(6):736-741. PubMed ID: 27818475 [Abstract] [Full Text] [Related]
24. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Yan AT, Shayne AJ, Brown KA, Gupta SN, Chan CW, Luu TM, Di Carli MF, Reynolds HG, Stevenson WG, Kwong RY. Circulation; 2006 Jul 04; 114(1):32-9. PubMed ID: 16801462 [Abstract] [Full Text] [Related]
25. Mechanisms for overestimating acute myocardial infarct size with gadolinium-enhanced cardiovascular magnetic resonance imaging in humans: a quantitative and kinetic study. Hammer-Hansen S, Bandettini WP, Hsu LY, Leung SW, Shanbhag S, Mancini C, Greve AM, Køber L, Thune JJ, Kellman P, Arai AE. Eur Heart J Cardiovasc Imaging; 2016 Jan 04; 17(1):76-84. PubMed ID: 25983233 [Abstract] [Full Text] [Related]
26. Left ventricular blood flow kinetic energy after myocardial infarction - insights from 4D flow cardiovascular magnetic resonance. Garg P, Crandon S, Swoboda PP, Fent GJ, Foley JRJ, Chew PG, Brown LAE, Vijayan S, Hassell MECJ, Nijveldt R, Bissell M, Elbaz MSM, Al-Mohammad A, Westenberg JJM, Greenwood JP, van der Geest RJ, Plein S, Dall'Armellina E. J Cardiovasc Magn Reson; 2018 Aug 30; 20(1):61. PubMed ID: 30165869 [Abstract] [Full Text] [Related]
27. Characterizing the inflammatory tissue response to acute myocardial infarction by clinical multimodality noninvasive imaging. Wollenweber T, Roentgen P, Schäfer A, Schatka I, Zwadlo C, Brunkhorst T, Berding G, Bauersachs J, Bengel FM. Circ Cardiovasc Imaging; 2014 Sep 30; 7(5):811-8. PubMed ID: 25049056 [Abstract] [Full Text] [Related]
29. Infarct tissue characteristics of patients with versus without early revascularization for acute myocardial infarction: a contrast-enhancement cardiovascular magnetic resonance imaging study. Olimulder MA, Kraaier K, Galjee MA, Scholten MF, van Es J, Wagenaar LJ, van der Palen J, von Birgelen C. Heart Vessels; 2012 May 30; 27(3):250-7. PubMed ID: 21598029 [Abstract] [Full Text] [Related]
30. Influence of microvascular obstruction on regional myocardial deformation in the acute phase of myocardial infarction: a speckle-tracking echocardiography study. Bergerot C, Mewton N, Lacote-Roiron C, Ernande L, Ovize M, Croisille P, Thibault H, Derumeaux G. J Am Soc Echocardiogr; 2014 Jan 30; 27(1):93-100. PubMed ID: 24269313 [Abstract] [Full Text] [Related]
31. Contrast-Enhanced CMR Overestimates Early Myocardial Infarct Size: Mechanistic Insights Using ECV Measurements on Day 1 and Day 7. Jablonowski R, Engblom H, Kanski M, Nordlund D, Koul S, van der Pals J, Englund E, Heiberg E, Erlinge D, Carlsson M, Arheden H. JACC Cardiovasc Imaging; 2015 Dec 30; 8(12):1379-1389. PubMed ID: 26699107 [Abstract] [Full Text] [Related]
32. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy. Ezekowitz JA, Armstrong PW, Granger CB, Theroux P, Stebbins A, Kim RJ, Patel MR. Am Heart J; 2010 Aug 30; 160(2):272-8. PubMed ID: 20691832 [Abstract] [Full Text] [Related]
33. Aborted myocardial infarction after primary percutaneous coronary intervention: magnetic resonance imaging insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Patel MR, Westerhout CM, Granger CB, Brener SJ, Fu Y, Siha H, Kim RJ, Armstrong PW. Am Heart J; 2013 Feb 30; 165(2):226-33. PubMed ID: 23351826 [Abstract] [Full Text] [Related]
34. Myocardial infarct heterogeneity assessment by late gadolinium enhancement cardiovascular magnetic resonance imaging shows predictive value for ventricular arrhythmia development after acute myocardial infarction. Robbers LF, Delewi R, Nijveldt R, Hirsch A, Beek AM, Kemme MJ, van Beurden Y, van der Laan AM, van der Vleuten PA, Tio RA, Zijlstra F, Piek JJ, van Rossum AC. Eur Heart J Cardiovasc Imaging; 2013 Dec 30; 14(12):1150-8. PubMed ID: 23764484 [Abstract] [Full Text] [Related]
35. Impact of myocardial scars on left ventricular deformation in type 2 diabetes mellitus after myocardial infarction by contrast-enhanced cardiac magnetic resonance. Gao Y, Xu HY, Guo YK, Wen XL, Shi R, Li Y, Yang ZG. Cardiovasc Diabetol; 2021 Oct 25; 20(1):215. PubMed ID: 34696783 [Abstract] [Full Text] [Related]